
Latest stock market news, company updates, and price movements. Stay updated with market trends, earnings insights, and investment analysis.
CRISIL has flagged multiple dividend-related dates, including an April 3, 2026 record date for a ₹28 final dividend and an April 23, 2026 record date for an interim dividend process.
Ally Financial is set to report Q1 2026 results on April 17, with analysts looking for $0.943 EPS and revenue of $2.1423 billion.
India’s March merchandise trade deficit narrowed to about $21 billion as exports rose and imports fell, even as the Iran war disrupted Gulf shipping routes and raised costs.
Alembic Pharmaceuticals received USFDA tentative approval for Bosutinib 400 mg tablets via a supplemental ANDA, expanding its oncology filings as the stock traded near ₹799 on NSE.
Nuvoco Vistas reported higher FY26 revenue and sharply improved profit, while recent quarterly disclosures highlighted volume growth, cost control, and ongoing integration of Vadraj Cement.
Nuvoco Vistas reported record Q3 FY26 volumes and sharply higher EBITDA, while advancing Vadraj Cement refurbishment and a 4 MMTPA eastern expansion to lift capacity to about 35 MMTPA.
Coal India reported a Q3FY26 profit decline, announced a ₹5.5 interim dividend, and flagged new capex plans including coking washeries and a 750 MWh BESS order.
Nifty’s sharp sell-off broke its consolidation range, dragged the index below key moving averages, and made 25,100-25,000 a decisive support zone amid bearish options cues.
Wipro reports Q4FY26 earnings on April 16 as its board weighs a share buyback and final dividend, with investors watching margins, guidance, and payout discipline.
Wipro reports Q4FY26 earnings on April 16, with investors watching guidance, margins, dividend outlook, and a potential ₹16,000-18,000 crore share buyback decision.
REC share price rose to ₹362.25 on 16 Apr 2026, up 2.73%, amid policy-led sentiment after RBI eased project-loan provisioning and Budget 2026-27 flagged REC-PFC restructuring.
Vedanta climbed after BofA upgraded the stock and raised its target to ₹840, citing a better aluminium outlook, supportive silver prices, and an estimated FY27 dividend yield above 6%.
Alembic Pharmaceuticals reported multiple USFDA outcomes, including generic Lamotrigine tablets, tentative clearance for Bosutinib 400 mg, and final approval for Macitentan 10 mg tablets.
A two-week US-Iran ceasefire holds as Pakistan works to restart talks, Israel-Lebanon contacts resume, and Strait of Hormuz tensions keep oil near $100 a barrel.
VA Tech Wabag secured a ₹1,000 crore CMWSSB contract for Chennai’s looped water transmission network, taking its total order book beyond ₹16,300 crore.
Citius TransNet Investment Trust’s InvIT issue opens April 17, 2026, with a ₹99–₹100 band and ₹1,105 crore target, while some published details differ on structure and pricing.